ToxiVen Biotech

News & Media

Repurposing Cancer Drugs Batimastat and Marimastat to Inhibit the Activity of a Group I Metalloprotease from the Venom of the Western Diamondback Rattlesnake, Crotalus atrox

Screening of FDA Approved Drugs Against SARS-CoV-2 Main Protease: Coronavirus Disease

We, ToxiVen Biotech, and our collaborators at the University of Reading along with TCR Multispeciality Hospital are extremely happy to announce our yet another groundbreaking research publication about 'low-cost public awareness campaign' has significantly increased the influx of people seeking treatment for snakebite. The news about this publication has been widely reported in several media.

Snakebite victims seek help in crucial early hours after awareness campaign, study shows

Low-cost snakebite public awareness campaigns to save lives

Low-cost snakebite public awareness campaign saves lives in Tamil Nadu

Tamil Researcher's article about snakes: Released in America's magazine

Venomous snakebites: Rapid action saves lives—A multifaceted community education programme increases awareness about snakes and snakebites among the rural population of Tamil Nadu, India